Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects

This publication has 20 references indexed in Scilit:

• Adjuvanted Influenza Vaccine
  BioDrugs, 2000
• Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly
  Vaccine, 1999
• The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice
  Vaccine, 1999
• Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons
  Vaccine, 1998
• The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial
  JAMA, 1994
• The Efficacy and Cost Effectiveness of Vaccination against Influenza among Elderly Persons Living in the Community
  New England Journal of Medicine, 1994
• Influenza: diagnosis, management, and prophylaxis
  BMJ, 1994
• Influenza vaccination and the elderly.
  BMJ, 1990
• Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial
  JAMA, 1990
• Frequency of adverse reactions after influenza vaccination
  The American Journal of Medicine, 1990